☆ 4.7 Review

Animal models of primary biliary cholangitis: status and challenges

CELL AND BIOSCIENCE (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes

Lindsey Kennedy et al.

Summary: This study investigated the impact of Sct/SR signaling pathway on the biliary secretory processes and injury in late-stage PBC models. The results showed that Sct/SR/CFTR/AE2 expression and bile bicarbonate levels were reduced in late-stage PBC models and human samples. Sct treatment decreased bile duct loss, ductular reaction, inflammation, and fibrosis, and restored the bile acid levels and DCJ structure. The study suggests that Sct treatment may be beneficial for individuals with late-stage PBC.

JOURNAL OF HEPATOLOGY (2023)

Add to Collection

Article Oncology

Spontaneous development of an autoimmune hepatitis - primary biliary cholangitis overlap syndrome in dnTGFβRII Aire-/- mice

Jie Long et al.

Summary: Aire and TGF-beta signaling are important in central and peripheral tolerance. Aire helps eliminate autoreactive T cells, while TGF-beta suppresses their activity. We studied mice with a defect in TGF-beta signaling and introduced the Aire gene. Surprisingly, these mice developed autoimmune cholangitis and hepatitis, resembling the AIH-PBC overlap syndrome.

JOURNAL OF PATHOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

Unique DUOX2(+)ACE2(+) small cholangiocytes are pathogenic targets for primary biliary cholangitis

Xi Li et al.

Summary: The numbers of DUOX2(+)ACE2(+) small cholangiocytes are inversely associated with disease severity in PBC. They may be the target of pIgR-mediated humoral responses. Protecting these cells and targeting anti-pIgR autoantibodies could be valuable strategies for therapeutic interventions in PBC.

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Rheumatology

Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis

Siyuan Tian et al.

Summary: Through bioinformatics analysis and experiment validation, we identified TXNIP, CD44, and ENTPD1 as promising biomarkers for risk stratification in PBC patients.

ARTHRITIS RESEARCH & THERAPY (2023)

Add to Collection

Article Gastroenterology & Hepatology

E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants

Yao Yang et al.

Summary: The study revealed unique epitopes in human PDC-E2 distinct from E. coli PDC-E2, suggesting a possible link between specific antibodies to ePDC-E2 and the development of PBC. Additionally, it was found that lipoic acid affects the conformation of ePDC-E2 and AMA recognition, potentially leading to the formation of anti-mitochondrial antibodies.

HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case-control study

Kosuke Matsumoto et al.

Summary: The study identified that poor environmental hygiene in childhood (vault toilets and unpaved roads) and chronic exposure to chemicals (smoking and hair dye use) are likely risk factors for the development of PBC in Japan.

JOURNAL OF GASTROENTEROLOGY (2022)

Add to Collection

Review Immunology

How genetic risk contributes to autoimmune liver disease

David Ellinghaus

Summary: Over the past decade, GWAS for AIH and GWAS/GWMA for PBC and PSC have successfully identified around 100 susceptibility loci in the human genome, with strong associations with the HLA locus. However, determining the causative variants and genes and understanding their effects on liver cells and the immune system remains challenging. PRSs based on current genome-wide data have limited predictive potential for individual disease risk. Comparisons between AIH, PBC, and PSC at the genome and transcriptome level could help in better understanding the shared genetic components of autoimmune liver diseases. Further research using scRNA-seq experiments in PBC and PSC holds promise in bridging the gap between genetics and disease.

SEMINARS IN IMMUNOPATHOLOGY (2022)

Add to Collection

Article Virology

Isolation of a Human Betaretrovirus from Patients with Primary Biliary Cholangitis

Mariam Goubran et al.

Summary: This study discovered a human betaretrovirus that is associated with primary biliary cholangitis (PBC) and various cancers. The researchers demonstrated the presence of this virus in PBC patients and its ability to replicate and transmit in cells.

VIRUSES-BASEL (2022)

Add to Collection

Article Immunology

The Proinflammatory Cytokines IL-18, IL-21, and IFN-γ Differentially Regulate Liver Inflammation and Anti-Mitochondrial Antibody Level in a Murine Model of Primary Biliary Cholangitis

Ya-Fei Xu et al.

Summary: This study investigated the roles of proinflammatory cytokines IL-18, IL-21, and IFN-gamma in the onset and progression of PBC using a mouse model. The study found that IL-18 deletion had no significant effect on disease progression, while IL-21 was necessary for AMA production independent of liver inflammation and cholangitis. IFN-gamma was responsible for both AMA production and liver inflammation in the model.

JOURNAL OF IMMUNOLOGY RESEARCH (2022)

Add to Collection

Article Immunology

Single-Cell Characterization of Hepatic CD8+ T Cells in a Murine Model of Primary Biliary Cholangitis

Yichen Han et al.

Summary: In this study, the researchers used a transgenic mouse model and single-cell RNA sequencing technology to investigate the role of CD8(+) T cell subsets in the pathogenesis of PBC. They found functional heterogeneity among these subsets and identified distinct characteristics of terminally differentiated CD8 alpha alpha T cells and CD8 alpha beta T cells. These findings enhance our understanding of the pathogenesis of PBC.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Oncology

The gut microbiome contributes to splenomegaly and tissue inflammation in a murine model of primary biliary cholangitis

Cheng-Bo Wang et al.

Summary: This study found that changes in the gut microbiome can affect splenomegaly and liver inflammation. Treatment with a combination of antibiotics can alleviate splenomegaly and liver inflammation, and reduce the accumulation and activation of immune cells.

ANNALS OF TRANSLATIONAL MEDICINE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

The IL-2A receptor pathway and its role in lymphocyte differentiation and function

Yuqian Li et al.

Summary: Murine myeloid cells develop from hemopoietic stem/progenitor cells, and different types of progenitor cells have varying differentiation potentials. Regulatory T cells (Tregs), an important cell subpopulation regulating immune responses, arise from hematopoietic stem cells in the bone marrow. The IL-2/IL-2R pathway plays a crucial role in regulating Tregs, and different subunit combinations of IL-2R can affect immune cell activation.

CYTOKINE & GROWTH FACTOR REVIEWS (2022)

Add to Collection

Article Cell Biology

The Clostridium Metabolite P-Cresol Sulfate Relieves Inflammation of Primary Biliary Cholangitis by Regulating Kupffer Cells

Hai-Yan Fu et al.

Summary: The study suggests that p-Cresol sulfate (PCS), a metabolite of Clostridium-metabolized tyrosine, can reduce inflammation in primary biliary cholangitis (PBC). This finding may contribute to the development of effective clinical strategies for treating PBC.

CELLS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Treatment of Primary Biliary Cholangitis First-Line and Second-Line Therapies

Chung-Heng Liu et al.

Summary: All patients with PBC should be treated with UDCA first and if there is an incomplete response, second-line therapies like OCA or bezafibrate should be considered. The use of OCA or fibrates in advanced or decompensated cirrhosis should be avoided, and for patients intolerant of UDCA, second-line agents may be used.

CLINICS IN LIVER DISEASE (2022)

Add to Collection

Article Immunology

Dual B-cell targeting therapy ameliorates autoimmune cholangitis

Weici Zhang et al.

Summary: The combination therapy of anti-BAFF and anti-CD20 was found to be more effective in reducing antibody levels, depleting B cells, and improving clinical symptoms in patients with primary biliary cholangitis (PBC).

JOURNAL OF AUTOIMMUNITY (2022)

Add to Collection

Review Virology

Linking Human Betaretrovirus with Autoimmunity and Liver Disease in Patients with Primary Biliary Cholangitis

Hussain Syed et al.

Summary: Primary biliary cholangitis (PBC) is an autoimmune liver disease potentially associated with betaretrovirus infection. Despite some evidence supporting this association, there is still a lack of definitive proof. This review presents different approaches to investigate the relationship between betaretrovirus and PBC, and provides an overview of how betaretrovirus infection may trigger autoimmunity and propagate biliary disease.

VIRUSES-BASEL (2022)

Add to Collection

Article Immunology

Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpression

Tihong Shao et al.

Summary: By inhibiting the JAK/STAT signaling pathway, the development and progression of autoimmune cholangitis can be effectively blocked. This study found that ruxolitinib treatment can reduce inflammation, lower autoantibody levels, and alter macrophage polarization, which holds important immunological and clinical significance for cholangitis.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Deletion of Mcpip1 in Mcpip1fl/flAlbCre mice recapitulates the phenotype of human primary biliary cholangitis

Jerzy Kotlinowski et al.

Summary: The study found that Mcpip1(fl/fl)Alb(Cre) mice recapitulated most features of human PBC in terms of intrahepatic B cell issues, while showing milder symptoms in myeloid cell issues.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Add to Collection

Article Gastroenterology & Hepatology

Enoxacin Up-Regulates MicroRNA Biogenesis and Down-Regulates Cytotoxic CD8 T-Cell Function in Autoimmune Cholangitis

Arata Itoh et al.

Summary: Enoxacin increases miRNA expression in dnTGF beta RII CD8 T cells, reduces the pathogenicity of CD8 T cells, and effectively stops the progression of autoimmune biliary disease. Targeting the miRNA pathway is a therapeutic approach to autoimmunity that corrects pathological miRNA abnormalities in autoreactive T cells.

HEPATOLOGY (2021)

Add to Collection

Article Immunology

CXCL12-CXCR4-Mediated Chemotaxis Supports Accumulation of Mucosal-Associated Invariant T Cells Into the Liver of Patients With PBC

Zhilei Chen et al.

Summary: The study showed that in patients with PBC, MAIT cells in the peripheral blood were significantly reduced and negatively correlated with alkaline phosphatase levels. MAIT cells from PBC patients accumulated in the liver, expressed higher levels of CXCR4 and CXCL12, produced more pro-inflammatory cytokines, and were influenced by elevated IL-18 levels. Targeting MAIT cells may be a potential therapeutic approach for PBC.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Recent advances in clinical practice: epidemiology of autoimmune liver diseases

Palak J. Trivedi et al.

Summary: Autoimmune liver diseases, including primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis, show meaningful changes in disease epidemiology with increasing incidence and prevalence in Europe, North America, and the Asia-Pacific region. Global variations exist in contemporary incidence rates, with age, sex, and race impacting clinical outcomes and the need for gastroenterology, hepatology, and organ transplant services.

GUT (2021)

Add to Collection

Article Immunology

5-Aza-2-deoxycytidine alleviates the progression of primary biliary cholangitis by suppressing the FoxP3 methylation and promoting the Treg/Th17 balance

Ting Jiang et al.

Summary: The study found an imbalance of the Treg/Th17 axis in PBC patients, with weakened Treg function being a potential reason for disease progression. The imbalance of the Treg/Th17 axis in PBC is likely influenced by FoxP3 hypermethylation, and treatment with DAC can suppress FoxP3 methylation to restore balance and alleviate liver lesions and inflammation in PBC.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection

Article Cell Biology

Gut microbiota contributes to sexual dimorphism in murine autoimmune cholangitis

Meng-Xing Huang et al.

Summary: Female dnTGF beta RII mice in the PBC model showed more severe lymphocytic infiltration and inflammatory responses, indicating a potential role of commensal gut microbiota in influencing sexual differences.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Modulation of CXCR1 and CXCR3 expression on NK cells via Tim-3 in a murine model of primary biliary cholangitis

Jiamin Xu et al.

Summary: Tim-3, expressed on various innate immune cells including NK cells, plays a crucial role in autoimmune diseases. In primary biliary cholangitis (PBC), the regulation of Tim-3 on NK cells remains unclear. Studies in a murine PBC model reveal dysregulation of Tim-3/Gal-9 impacting the local immune microenvironment and potential for Tim-3 pathway modulation of chemokine responses in NK cells during autoimmunity.

MOLECULAR IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Interleukin 23 Produced by Hepatic Monocyte-Derived Macrophages Is Essential for the Development of Murine Primary Biliary Cholangitis

Debby Reuveni et al.

Summary: IL-23 plays a crucial role in the pathogenesis of PBC, with IL-23 derived from hepatic monocyte-derived macrophages being particularly significant. Studies using a murine model showed that IL-23 produced by specific MNPs contributes to the severity of PBC, suggesting potential for new immune-based therapies for PBC patients.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Interleukin-30 Suppresses Not Only CD4+ T Cells but Also Regulatory T Cells in Murine Primary Biliary Cholangitis

Hung-Wen Chen et al.

Summary: IL-30 treatment reduces activated CD4(+) T cells and regulatory T cells, but does not suppress liver inflammation in the murine model of PBC.

BIOMEDICINES (2021)

Add to Collection

Article Immunology

Liver-resident NK cells suppress autoimmune cholangitis and limit the proliferation of CD4+ T cells

Zhi-Bin Zhao et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection

Review Allergy

Animal Models of Autoimmune Liver Diseases: a Comprehensive Review

Shou-Pei Liu et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)

Add to Collection

Review Gastroenterology & Hepatology

Diagnosis and treatment of primary biliary cholangitis

Alena Laschtowitz et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Add to Collection

Article Immunology

Sirtuin 1 activation alleviates primary biliary cholangitis via the blocking of the NF-κB signaling pathway

Yong Li et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2020)

Add to Collection

Article Medicine, Research & Experimental

Kupffer Cells Regulate Natural Killer Cells Via the NK group 2, Member D (NKG2D)/Retinoic Acid Early Inducible-1 (RAE-1) Interaction and Cytokines in a Primary Biliary Cholangitis Mouse Model

Hai-Yan Fu et al.

MEDICAL SCIENCE MONITOR (2020)

Add to Collection

Review Immunology

Pathogen infections and primary biliary cholangitis

A. Tanaka et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

TCRβ repertoire of memory T cell reveals potential role for Escherichia coli in the pathogenesis of primary biliary cholangitis

Xianliang Hou et al.

LIVER INTERNATIONAL (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis

Lindsey Kennedy et al.

FASEB JOURNAL (2019)

Add to Collection

Article Immunology

Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitis

Yikang Li et al.

JOURNAL OF AUTOIMMUNITY (2019)

Add to Collection

Review Gastroenterology & Hepatology

Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis

Na Zeng et al.

HEPATOLOGY INTERNATIONAL (2019)

Add to Collection

Article Immunology

The challenges of primary biliary cholangitis: What is new and what needs to be done

Terziroli Beretta-Piccoli Benedetta et al.

JOURNAL OF AUTOIMMUNITY (2019)

Add to Collection

Review Gastroenterology & Hepatology

Diagnosis and Management of Primary Biliary Cholangitis

Zobair M. Younossi et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Promoter hypermethylation of the AE2/SLC4A2 gene in PBC

Fabian Arenas et al.

JHEP REPORTS (2019)

Add to Collection

Article Immunology

Proteomic analysis reveals distinctive protein profiles involved in CD8+ T cell-mediated murine autoimmune cholangitis

Weici Zhang et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

The interplay of type I and type II interferons in murine autoimmune cholangitis as a basis for sex-biased autoimmunity

Heekyong R. Bae et al.

HEPATOLOGY (2018)

Add to Collection

Article Immunology

The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis via CD8+ T Cells but Promotes Colitis via CD4+ T Cells

Qing-Zhi Liu et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Immunology

Endogenous IL-10 maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis

Yu-Hsin Hsueh et al.

JOURNAL OF AUTOIMMUNITY (2018)

Add to Collection

Article Cell & Tissue Engineering

Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9

Junyu Fan et al.

STEM CELL RESEARCH & THERAPY (2018)

Add to Collection

Article Immunology

The Critical Role of Chemokine (C-C Motif) Receptor 2-Positive Monocytes in Autoimmune Cholangitis

Debby Reuveni et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Immunology

Gut microbiota translocation promotes autoimmune cholangitis

Hong-Di Ma et al.

JOURNAL OF AUTOIMMUNITY (2018)

Add to Collection

Article Immunology

The immunobiology of female predominance in primary biliary cholangitis

Alessi Gerussi et al.

JOURNAL OF AUTOIMMUNITY (2018)

Add to Collection

Article Immunology

Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20-and FcγR-Expressing Mice

Yuki Moritoki et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Immunology

Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8+ T cell activation

Hong-Di Ma et al.

JOURNAL OF AUTOIMMUNITY (2017)

Add to Collection

Article Gastroenterology & Hepatology

The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation

Elisabeth Schrumpf et al.

JOURNAL OF HEPATOLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

A Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein Immunization

Wen-Tao Ma et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Review Pathology

A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis

Patrick S. C. Leung et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)

Add to Collection

Article Gastroenterology & Hepatology

Chronic Expression of Interferon-Gamma Leads to Murine Autoimmune Cholangitis With a Female Predominance

Heekyong R. Bae et al.

HEPATOLOGY (2016)

Add to Collection

Review Gastroenterology & Hepatology

It is time to change primary biliary cirrhosis (PBC): New nomenclature from cirrhosis to cholangitis, and upcoming treatment based on unveiling pathology

Shinji Shimoda et al.

HEPATOLOGY RESEARCH (2016)

Add to Collection

Article Immunology

Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy

Jing-Bo Yang et al.

JOURNAL OF AUTOIMMUNITY (2016)

Add to Collection

Article Immunology

AAV-IL-22 modifies liver chemokine activity and ameliorates portal inflammation in murine autoimmune cholangitis

Yu-Hsin Hsueh et al.

JOURNAL OF AUTOIMMUNITY (2016)

Add to Collection

Article Oncology

Dysregulation of peritoneal cavity B1a cells and murine primary biliary cholangitis

Yan-Qing Yang et al.

ONCOTARGET (2016)

Add to Collection

Article Multidisciplinary Sciences

Dual Roles of IFN-γ and IL-4 in the Natural History of Murine Autoimmune Cholangitis: IL-30 and Implications for Precision Medicine

Bi-Jhen Syu et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Article Gastroenterology & Hepatology

The biliary epithelium presents antigens to and activates natural killer T cells

Elisabeth Schrumpf et al.

HEPATOLOGY (2015)

Add to Collection

Article Oncology

CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis

Axel R. Concepcion et al.

ONCOTARGET (2015)

Add to Collection

Article Gastroenterology & Hepatology

Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease

David Sharon et al.

LIVER INTERNATIONAL (2015)

Add to Collection

Article Immunology

Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD). B6 (Idd10/Idd18) mice

J. J. Wang et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)

Add to Collection

Article Immunology

Anion exchanger 2 is critical for CD8+T cells to maintain pHi homeostasis and modulate immune responses

Axel R. Concepcion et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

IL-12/Th1 and IL-23/Th17 Biliary Microenvironment in Primary Biliary Cirrhosis: Implications for Therapy

Chen-Yen Yang et al.

HEPATOLOGY (2014)

Add to Collection

Article Immunology

Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Rα-/- mice

Yuan Yao et al.

JOURNAL OF AUTOIMMUNITY (2014)

Add to Collection

Article Immunology

Murine autoimmune cholangitis requires two hits: Cytotoxic KLRG1+ CD8 effector cells and defective T regulatory cells

Wenting Huang et al.

JOURNAL OF AUTOIMMUNITY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Clonality, Activated Antigen-Specific CD8+ T Cells, and Development of Autoimmune Cholangitis in dnTGFβRII Mice

Kazuhito Kawata et al.

HEPATOLOGY (2013)

Add to Collection

Article Multidisciplinary Sciences

Identification of Potential Cytokine Pathways for Therapeutic Intervention in Murine Primary Biliary Cirrhosis

Kazuhito Kawata et al.

PLOS ONE (2013)

Add to Collection

Article Gastroenterology & Hepatology

Aberrant TGF-β1 signaling contributes to the development of primary biliary cirrhosis in murine model

Bin Liu

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Add to Collection

Article Cell Biology

B cells promote hepatic inflammation, biliary cyst formation, and salivary gland inflammation in the NOD.c3c4 model of autoimmune cholangitis

Yuki Moritoki et al.

CELLULAR IMMUNOLOGY (2011)

Add to Collection

Article Gastroenterology & Hepatology

B Cell Depletion Therapy Exacerbates Murine Primary Biliary Cirrhosis

Amy Dhirapong et al.

HEPATOLOGY (2011)

Add to Collection

Article Gastroenterology & Hepatology

Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models

Guangzhi Zhang et al.

JOURNAL OF HEPATOLOGY (2011)

Add to Collection

Article Gastroenterology & Hepatology

Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis

Christophe Corpechot et al.

JOURNAL OF HEPATOLOGY (2010)

Add to Collection

Article Gastroenterology & Hepatology

Deficiency in Regulatory T Cells Results in Development of Antimitochondrial Antibodies and Autoimmune Cholangitis

Weici Zhang et al.

HEPATOLOGY (2009)

Add to Collection

Article Gastroenterology & Hepatology

Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis

January T. Salas et al.

GASTROENTEROLOGY (2008)

Add to Collection

Article Gastroenterology & Hepatology

Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease

Kanji Wakabayashi et al.

HEPATOLOGY (2008)

Add to Collection

Article Gastroenterology & Hepatology

IL-2 receptor α-/- mice and the development of primary biliary cirrhosis

Kanji Wakabayashi et al.

HEPATOLOGY (2006)

Add to Collection

Article Immunology

Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-β receptor II dominant-negative mice

Sabine Oertelt et al.

JOURNAL OF IMMUNOLOGY (2006)

Add to Collection

Article Immunology

NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis

Junichiro Irie et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2006)

Add to Collection

Article Gastroenterology & Hepatology

Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration

C Okada et al.

LIVER INTERNATIONAL (2005)

Add to Collection

Article Immunology

Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis

KA Padgett et al.

JOURNAL OF AUTOIMMUNITY (2005)

Add to Collection

Article Immunology

Genetic control of autoimmunity: Protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain

S Koarada et al.

JOURNAL OF IMMUNOLOGY (2004)

Add to Collection

Article Gastroenterology & Hepatology

Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium

C Selmi et al.

HEPATOLOGY (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.